IKENA ONCOLOGY INC has a total of 17 patent applications. Its first patent ever was published in 2018. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are VIIV HEALTHCARE UK LTD, Inthera Bioscience AG and ARAXES PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Special acyclic compounds | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Castro Alfredo C | 12 |
#2 | Evans Catherine Anne | 8 |
#3 | Zhang Michelle | 2 |
#4 | Nolan James | 2 |
#5 | Catherine Anne Evans | 1 |
#6 | Alfredo C Castro | 1 |
#7 | Evans Catherine A | 1 |
#8 | Castro Alfredo | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021076966A1 | Pegylated kynureninase enzymes and uses thereof for the treatment of cancer | |
WO2020243423A1 | Tead inhibitors and uses thereof | |
WO2020243415A2 | Tead inhibitors and uses thereof | |
WO2020081636A1 | Indole ahr inhibitors and uses thereof | |
CA3073051A1 | Ahr inhibitors and uses thereof |